Confirmed Exhibitors

botiss biomaterials is one of the leading companies in the field of dental bone and tissue regeneration, based in Germany.

As a future-oriented company, botiss acts as a link between developers, researchers and clinicians, with a key focus on the everyday-practice experience. This is the driving force that leads us to a continuous development of new materials and to the optimization of established products.

The comprehensive range of high-quality, clinically proven solutions includes membranes for guided tissue and bone regeneration and soft tissue reconstruction, as well as a full range of bovine, allogeneic and synthetic bone substitute materials.

The indication-oriented products are used worldwide in over 100 countries and are supported by both clinical studies and many years of clinical experience.

Effectiveness, simplicity, hi-tech : these are META’s key guidelines. META has been able to earn a conspicuous and active role in the medical and dental fields, thanks to the extreme care given to every single phase of its manufacturing activity. META sees everyone in its departments fully committed in creating something that follows two fundamental criteria: the simplification and the improvement of the current clinical and surgical procedures, where Safescraper and Micross are the great example! More information.

PerioChip is a second line treatment in the care and maintenance of Periodontal Disease. It comes in the form of an innovative, easy to insert biodegradable chip containing 2.5 mg of chlorhexidine digluconate – an ideal non-antibiotic adjunct treatment to reduce pocket depth in adults with periodontitis.
It has been demonstrated clinically to be effective and well tolerated for periodontal pockets with a depth of 5 mm or more.The biodegradable gelatin matrix contains 2.5 mg of chlorhexidine digluconate which is released slowly over a period of 7 days.
A high local concentration of chlorhexidine eliminates 99.9%. of bacteria in the pocket and suppresses the early recovery of the periodontal pathogenic biofilm for up to 11 weeks.
PerioChip should be used as part of a medium to long term periodontal treatment plan. Give your patients the benefits of an easy, local non-antibiotic solution that is well tolerated and clinically effective.